Complement Factor P (Properdin)

Extinction Coeff. A280 nm = 1.78 at 1.0 mg/mL Molecular weight 53,000 Da (single chain) Purity >90% by SDS-PAGE General Description Complement factor P (properdin) is purified from normal human serum. Factor P is a 53,000 dalton cationic protein that circulates in blood in the form of dimers, trimers and tetramers. It binds rapidly to C3b on surfaces where complement has begun to activate. Properdin binds most avidly to C3b,Bb the alternative pathway C3/C5 convertase, but also binds to C3b Thus, properdin is an accelerator (positive regulator) of complement activation. Properdin has recently been proposed to be able to also initiate activation of the alternative pathway by binding to the target surface and initiating C3/C5 convertase formation (Kemper C. and Hourcade D.E. (2008)). Physical Characteristics & Structure The basic subunit of this protein is a 53,000 dalton single chain molecule which is composed of six thrombospondin-like repeat (TSR) domains. These basic units are linked at the ends (C-terminal to N-terminal) to form circular dimers, trimers, tetramers and perhaps higher forms in blood (Pangburn, M.K. (1989)). Electron microscopic images (Smith, C.A. et al. (1984)) have clearly demonstrated these structures. Higher oligomers of properdin are formed upon freeze thaw and perhaps during complement activation and were originally called “activated” properdin due to their enhanced ability to bind and activate complement. Properdin has a rare post-translational modification in that its tryptophan residues are highly mannosylated (Hartmann, S. and Hofsteenge, J. (2000)). There is also a single N-linked glycosylation site near the C-terminal. These contribute to a carbohydrate content estimated at 10%. Properdin is highly positively charged at neutral pH and has a pI greater than 9.5. It is one of the most positively charged proteins in blood (Morley, B.J. and Walport, M.J. (2000)). Function Properdin binds most avidly to C3b,Bb the alternative pathway C3/C5 convertase, but also binds to C3b P,C3b complexes. Thus, properdin is an accelerator (positive regulator) of complement activation. Assays Assays depend on the ability of properdin to bind to clusters of C3b or to accelerate the activation of the alternative pathway. ELISA assays for protein may be performed by coating plates with excess C3b, binding properdin and detection with goat anti-Properdin. Functional assays are best performed using P-depleted serum and then measuring the accelerated lysis of rabbit erythrocytes in the presence of properdin and MgEGTA. Lysis does occur slowly in the absence of properdin so these assays must be timed assays to compare the rates of lysis with and without properdin. Assays for “activated” properdin consist of incubating properdin in NHS for extended periods of time (30 to 60 min) and measuring the residual C3 activity using C3-depleted serum and rabbit erythrocytes. In vivo Blood contains approximately 5 µg/mL properdin (Pangburn, M.K. (1989)). Properdin does not appear to be synthesized in the liver where most complement proteins are synthesized. It is primarily made by monocytes, T-cells and neutrophils. In neutrophils it is stored in granules that release the properdin in response to C5a, FMLP, IL8 and TNF-alpha. Regulation See In vivo above. Genetics The gene for properdin is X-linked and resides on the short arm of the X chromosome between Xp11.3-Xp11.23. The gene is 6 kb is size with 10 exons. Accession numbers: Human (X70872, X70872.1, X57748, M83652, S49355), Mouse (X12905), Guinea pig (S81116). Deficiencies Deficiencies are rare and can be the result of a total lack of properdin protein in blood or the presence of immunochemically detectable, but functionally inactive properdin. Diseases Deficiency of properdin results in recurrent fulminant meningococcal infections. Neisserial infections typically occur in young males, progress rapidly and can be fatal. Reoccurrences are rare probably due to the generation of protective antibodies during the first incident. Precautions/Toxicity/Hazards This protein is purified from human serum, therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II. Hazard Code: B WGK Germany 3 MSDS available upon request.

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet